India, Nov. 3 -- Shares of Rhythm Pharmaceuticals, Inc. (RYTM) are falling 11 percent on Tuesday morning after the announcement of its third-quarter financial results, reporting a narrower loss on higher revenue.
Shares of the company slipped 11.17 percent to $83.00 on the Nasdaq, compared with the previous closing price of $93.44. The stock has traded in a 52-week range of $74.50 to $122.20.
Net loss attributable to common stockholders totaled $42.4 million, or $0.61 per share, compared to $54.3 million, or $0.82 per share, in the previous year. Total revenues increased to $92.1 million from last year's $51.3 million.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from ...